Vertex Pharmaceuticals (VRTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Vertex Pharmaceuticals

    NASDAQ: VRTX · Real-Time Price · USD
    403.12
    -5.73 (-1.40%)
    At close: Oct 03, 2025, 3:59 PM
    403.56
    0.11%
    After-hours: Oct 03, 2025, 07:56 PM EDT

    Vertex Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 4.57B 10.37B 10.5B 6.79B
    Short-Term Investments
    		 1.55B 849.2M 274.5M 729.9M
    Long-Term Investments
    		 5.11B 2.5B 112.2M n/a
    Other Long-Term Assets
    		 999.3M 895.3M 409.6M 110.8M
    Receivables
    		 1.61B 1.56B 1.44B 1.14B
    Inventory
    		 1.21B 738.8M 460.6M 353.1M
    Other Current Assets
    		 206.5M 86.1M 121.9M 103.7M
    Total Current Assets
    		 9.6B 14.14B 13.23B 9.56B
    Property-Plant & Equipment
    		 2.58B 1.45B 1.46B 1.42B
    Goodwill & Intangibles
    		 1.91B 1.93B 1.69B 1.4B
    Total Long-Term Assets
    		 12.94B 8.59B 4.92B 3.87B
    Total Assets
    		 22.53B 22.73B 18.15B 13.43B
    Account Payables
    		 413M 364.9M 303.9M 195M
    Deferred Revenue
    		 206.8M 170.3M 159.6M 171.7M
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 31.4M 50.7M 62.5M 16.5M
    Total Current Liabilities
    		 3.56B 3.55B 2.74B 2.14B
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 901.8M 877.7M 685.8M 303.3M
    Total Long-Term Liabilities
    		 2.56B 1.6B 1.5B 1.19B
    Total Liabilities
    		 6.12B 5.15B 4.24B 3.33B
    Total Debt
    		 1.75B 808.4M 899.7M 967.4M
    Book Value
    		 16.41B 17.58B 13.91B 10.1B
    Book Value Per Share
    		 63.73 68.22 54.33 39.19
    Common Stock
    		 2.6M 2.6M 2.6M 2.5M
    Retained Earnings
    		 9.61B 10.14B 6.52B 3.2B
    Comprehensive Income
    		 127.8M -14.3M 800K 15.9M
    Shareholders Equity
    		 16.41B 17.58B 13.91B 10.1B
    Total Investments
    		 6.65B 3.35B 386.7M 729.9M

    Add to Watchlist